Bernhard Homey
0000-0002-5784-4146
Publication & Citation Trends
Publications
0 total
German Cohort Observational Study to Investigate the Short‐ and Long‐Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP) OA
Cited by 5
Semantic Scholar
181 JAK1/2 inhibition reprograms the T cell compartment to facilitate resolution of scarring alopecia
Cited by 0
Semantic Scholar
Investigating the Effect of Enzymatically-Derived Blackcurrant Extract on Skin Staphylococci Using an In Vitro Human Stratum Corneum Model OA
Cited by 2
Semantic Scholar
Intermittent Pneumatic Impulse Compression in the Treatment of Stasis Dermatitis—A Monocenter Randomized Controlled Trial
Cited by 2
Semantic Scholar
Lyophilized Extract from the Larvae of the Blowfly Lucilia sericata as a New Strategy for the Management of Chronic Wounds OA
Cited by 3
Semantic Scholar
The effects of cholecalciferol and afamelanotide on vitamin D levels in erythropoietic protoporphyria; a multicentre cohort study. OA
Cited by 3
Semantic Scholar
JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia OA
Cited by 16
Semantic Scholar
59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
Cited by 0
Semantic Scholar
Research Topics
Dermatology and Skin Diseases
(121)
Immunotherapy and Immune Responses
(63)
Chemokine receptors and signaling
(46)
Allergic Rhinitis and Sensitization
(44)
T-cell and B-cell Immunology
(38)
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Palo Alto Research Center
University of California, San Francisco
Medical University of Graz
University of Münster
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.